Top Ten Retail Investor Buys & Sells for week ending 25 May 2007

Angus Rigby, Chief Executive Officer, TD Waterhouse, commented: As the markets wind down for another bank holiday weekend, we look back at the key movers and shakers on the scene this week. Drug developer GlaxoSmithKline experienced strong trading activity with TD Waterhouse customers amidst reports that its popular type 2 diabetes drug Avandia increases the risk of heart attacks. Shares in the stock are down by around 9 per cent on last week following reports from US researchers that the drug increases the risk of heart death by 64% and the risk of heart attack by 43%. GlaxoSmithKline disputed these claims but a subsequent governmental evaluation of the pill which confirmed these safety concerns is expected to damage the company's overall revenue performance.

Meanwhile Blinkx, which made its debut on the AIM market this week after demerging from contextual internet search specialist Autonomy, also enters our Top 10 Buys. Blinkx is hoping to follow in the footsteps of other internet video companies such as YouTube, by offering 13 million hours of indexed video content. Our clients eyed up the potential for growth in the online video market and Blinkx, the world's largest internet video search provider and bought strongly into stock this week. The share price rocketed to a high of 65p per share during the initial trading frenzy after it opened on the market before closing trade with a market capitalisation of £175m.

Elsewhere on the market, TD Waterhouse investors were upbeat on Woolworths’ stock this week following the news that the retailer is to supply CDs, video games and DVDs to Wal-Mart-owned Asda. This deal is hoped to add £200m to the Company’s annual turnover, however the share price sank to 52 week lows of 27.75p earlier this week, down 8 per cent on last year. Long term investors are evidently hoping the Asda tie-up could mark the end of Woolworths’ retail slump but analysts argue that the deal could accelerate break up negotiations after months of weak market performance for the Company.

Top 10 Buys
1 BT Group
2 Glaxosmithkline
3 Partygaming
4 British Airways
5 Marks & Spencer Group
6 Royal Bank of Scotland
7 Tate & Lyle
8 Woolworths Group
9 Blinkx PLC
10 BP


Top 10 Sells
1 BP
2 Partygaming
3 Vodafone Group
4 BT Group
5 Barclays
6 Royal Bank of Scotland
7 Experian Group
8 EMI Group
9 Royal Dutch Shell
10 Glaxosmithkline